Antidepressant Citalopran Hbr CAS: 59729-32-7

The second generation of antidepressants has a strong and specific inhibitory effect on the reabsorption of serotonin. For antidepressant, senile dementia and multiple infarct dementia.
Severe Depression (MDD)
Major depression or agitation (at least 2 weeks), mainly including the following symptoms: depression, decreased interest, significant changes in weight or appetite, insomnia or lethargy, mental exercise excitement or delay, fatigue , Guilt or inferiority, slow thinking or inattention, suicide attempts or thoughts.
Generalized anxiety (GAD)
Manifested as excessive anxiety and worry, for at least 6 months. Mainly have the following symptoms: irritability, fatigue, inattention, excitement, muscle tension and sleep disorders.
Citalopram HBr is ramification of Phthalane, a new antidepressant, which has most opposite-selectivity to inhibiting resorption for 5-hydroxytryptamine (5-HT) in congener drugs. Citalopram HBr can inhibit resorption of 5-HT effectively, and is slight to resorption of dopamine and noradrenalin, and is weak or almost none to appetency of alkali-toadstool, histamine and 5-HT acceptor. The drug is all resultful for en-dogenesis and non-endogenesis suffer, and also does not affect heart-conduction system and blood pressure, does not damage surfers' cognizing function and psychomotor, does not enhance inhibiting function resulting from ethanol.